BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 184697 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3 SNPPWIUOZRMYNY-UHFFFAOYSA-N 50048392 BUPROPION HYDROCHLORIDE::CHEMBL894::2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one::BUPROPION::US9944618, Compound ID No. 176 Sodium-dependent serotonin transporter Homo sapiens >10000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50048392 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2273&target=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50048392&enzyme=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search 444 103978858 CHEMBL894 DB01156 C06860 1 METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRICWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIITPGTFKERIIKSITPETPTEIPCGDIRLNAV 6VRL,6VRK,6VRH,7TXT,7LWD,6DZZ,7LIA,7LI9,7LI8,7LI6,7MGW,7LI7,6DZV Sodium-dependent serotonin transporter SC6A4_HUMAN P31645 Q5EE02 184698 CNCCCN1c2ccccc2CCc3c1cccc3 InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3 HCYAFALTSJYZDH-UHFFFAOYSA-N 35229 Desmethylimipramine::3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1-amine::monodemethylimipramine::Desipramin::5-(gamma-methylaminopropyl)iminodibenzyl::norimipramine::CHEMBL72::DESIPRAMINE HYDROCHLORIDE::demethylimipramine::N-(3-methylaminopropyl)iminobibenzyl::DMI::Desipramine::US9944618, Compound ID No. 174 Sodium-dependent serotonin transporter Homo sapiens 179 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2273&target=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=35229&enzyme=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search DSM 7Q19,2QJU,7Q2N,7Q2O,7Q2P,8HFI,8WGR,2QB4 2995 85753308 CHEMBL72 DB01151 C06943 1 METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRICWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIITPGTFKERIIKSITPETPTEIPCGDIRLNAV 6VRL,6VRK,6VRH,7TXT,7LWD,6DZZ,7LIA,7LI9,7LI8,7LI6,7MGW,7LI7,6DZV Sodium-dependent serotonin transporter SC6A4_HUMAN P31645 Q5EE02 184699 CNCC[C@H](c1ccccc1)Oc2ccc(cc2)C(F)(F)F InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 30130 Prozac::cid_62857::Fluoxetin::CHEMBL41::CHEMBL1201082::Fluoxetine::US9120771, Fluoxetine Sodium-dependent serotonin transporter Homo sapiens 7 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2273&target=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=30130&enzyme=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search RFX 4MM8,3GWV 3386 85147891 CHEMBL1201082CHEMBL41 DB00472 1 METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRICWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIITPGTFKERIIKSITPETPTEIPCGDIRLNAV 6VRL,6VRK,6VRH,7TXT,7LWD,6DZZ,7LIA,7LI9,7LI8,7LI6,7MGW,7LI7,6DZV Sodium-dependent serotonin transporter SC6A4_HUMAN P31645 Q5EE02 184700 CN(C)CCCN1c2ccccc2CCc3c1cccc3 InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3 BCGWQEUPMDMJNV-UHFFFAOYSA-N 50010859 CHEMBL11::Imipramin::IMIPRAMINE HYDROCHLORIDE::IMIPRAMINE PAMOATE Sodium-dependent serotonin transporter Homo sapiens 19 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50010859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2273&target=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50010859&enzyme=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search IXX 2Q72,7LWD,6G9B 3696 103923605 CHEMBL11 DB00458 C07049 1 METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRICWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIITPGTFKERIIKSITPETPTEIPCGDIRLNAV 6VRL,6VRK,6VRH,7TXT,7LWD,6DZZ,7LIA,7LI9,7LI8,7LI6,7MGW,7LI7,6DZV Sodium-dependent serotonin transporter SC6A4_HUMAN P31645 Q5EE02 184701 COC(=O)[C@H]([C@@H]1CCCCN1)c1ccccc1 InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3 DUGOZIWVEXMGBE-UHFFFAOYSA-N 50050098 CHEMBL542556::METHYLPHENIDATE::(S)-Phenyl-(S)-piperidin-2-yl-acetic acid methyl ester; hydrochloride Sodium-dependent serotonin transporter Homo sapiens >10000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50050098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2273&target=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50050098&enzyme=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search 10657292 103947285 CHEMBL542556 C07196 1 METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRICWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIITPGTFKERIIKSITPETPTEIPCGDIRLNAV 6VRL,6VRK,6VRH,7TXT,7LWD,6DZZ,7LIA,7LI9,7LI8,7LI6,7MGW,7LI7,6DZV Sodium-dependent serotonin transporter SC6A4_HUMAN P31645 Q5EE02 184702 CN1Cc2c(cccc2N)[C@@H](C1)c3ccccc3 InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3 XXPANQJNYNUNES-UHFFFAOYSA-N 50005548 (+/-)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine (Nomifensine)::2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::CHEMBL273575::(+)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::(Nomifensine) 2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-8-amine::NOMIFENSINE2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::(-)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine(Nomifensine)::NOMIFENSINE Sodium-dependent serotonin transporter Homo sapiens 4872 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50005548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2273&target=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50005548&enzyme=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search A1LX5 8Y91 4528 103919027 CHEMBL273575 DB04821 1 METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRICWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIITPGTFKERIIKSITPETPTEIPCGDIRLNAV 6VRL,6VRK,6VRH,7TXT,7LWD,6DZZ,7LIA,7LI9,7LI8,7LI6,7MGW,7LI7,6DZV Sodium-dependent serotonin transporter SC6A4_HUMAN P31645 Q5EE02 184703 CCOc1ccccc1O[C@@H](c2ccccc2)[C@@H]3CNCCO3 InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3 CBQGYUDMJHNJBX-UHFFFAOYSA-N 35226 Vestra::Reboxetine::(S,S)-reboxetine Sodium-dependent serotonin transporter Homo sapiens 440 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2273&target=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=35226&enzyme=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search A1D9Y 8ZP1 65856 85753305 DB00234 1 METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRICWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIITPGTFKERIIKSITPETPTEIPCGDIRLNAV 6VRL,6VRK,6VRH,7TXT,7LWD,6DZZ,7LIA,7LI9,7LI8,7LI6,7MGW,7LI7,6DZV Sodium-dependent serotonin transporter SC6A4_HUMAN P31645 Q5EE02 184704 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Sodium-dependent serotonin transporter Homo sapiens 77 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2273&target=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Sodium-dependent+serotonin+transporter&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRICWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIITPGTFKERIIKSITPETPTEIPCGDIRLNAV 6VRL,6VRK,6VRH,7TXT,7LWD,6DZZ,7LIA,7LI9,7LI8,7LI6,7MGW,7LI7,6DZV Sodium-dependent serotonin transporter SC6A4_HUMAN P31645 Q5EE02 184705 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE 5-hydroxytryptamine receptor 1A Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 184706 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE 5-hydroxytryptamine receptor 1B Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 184707 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE 5-hydroxytryptamine receptor 1D Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 184708 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE 5-hydroxytryptamine receptor 2A Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 184709 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE 5-hydroxytryptamine receptor 2C Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 184710 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE 5-hydroxytryptamine receptor 3A Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5137&target=5-hydroxytryptamine+receptor+3A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=5-hydroxytryptamine+receptor+3A&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLLTNYRKGVRPVRDWRKPTTVSIDVIVYAILNVDEKNQVLTTYIWYRQYWTDEFLQWNPEDFDNITKLSIPTDSIWVPDILINEFVDVGKSPNIPYVYIRHQGEVQNYKPLQVVTACSLDIYNFPFDVQNCSLTFTSWLHTIQDINISLWRLPEKVKSDRSVFMNQGEWELLGVLPYFREFSMESSNYYAEMKFYVVIRRRPLFYVVSLLLPSIFLMVMDIVGFYLPPNSGERVSFKITLLLGYSVFLIIVSDTLPATAIGTPLIGVYFVVCMALLVISLAETIFIVRLVHKQDLQQPVPAWLRHLVLERIAWLLCLREQSTSQRPPATSQATKTDDCSAMGNHCSHMGGPQDFEKSPRDRCSPPPPPREASLAVCGLLQELSSIRQFLEKRDEIREVARDWLRVGSVLDKLLFHIYLLAVLAYSITLVMLWSIWQYA 8BLB,4PIR,8C21,8C20,8C1Z,8C1W,6Y5B,6Y5A,6Y59,8BLA,8BL8 5-hydroxytryptamine receptor 3A 5HT3A_HUMAN P46098 B4DSY6 G5E986 O60854 Q7KZM7 Q99918 Q9BSZ9 184711 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE 5-hydroxytryptamine receptor 4 Cavia porcellus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000084&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MDKLDANVSSKEGFGSVEKVVLLTFLSAVILMAILGNLLVMVAVCRDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWVYGEMFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPMFISFLPIMQGWNNIGIVDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHARQIQVLQRAGAPAEGRPQPADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQLWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDTVECGGQWESQCHPAASSPLVAAQPIDT 5-hydroxytryptamine receptor 4 5HT4R_CAVPO O70528 184712 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE 5-hydroxytryptamine receptor 6 Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2142&target=5-hydroxytryptamine+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=5-hydroxytryptamine+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN 7XTB,8JLZ,7YS6 5-hydroxytryptamine receptor 6 5HT6R_HUMAN P50406 Q13640 Q5TGZ1 184713 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE 5-hydroxytryptamine receptor 7 Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3431&target=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=5-hydroxytryptamine+receptor+7&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD 7XTC 5-hydroxytryptamine receptor 7 5HT7R_HUMAN P34969 B5BUP6 P78336 P78372 P78516 Q5VX01 Q5VX02 Q5VX03 184714 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Adenosine receptor A1 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5768&target=Adenosine+receptor+A1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Adenosine+receptor+A1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MPPYISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKTVVTQRRAAVAIAGCWILSLVVGLTPMFGWNNLSVVEQDWRANGSVGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPTCQKPSILIYIAIFLTHGNSAMNPIVYAFRIHKFRVTFLKIWNDHFRCQPKPPIDEDLPEEKAED Adenosine receptor A1 AA1R_RAT P25099 184715 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Adenosine receptor A2b Bos taurus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000160&target=Adenosine+receptor+A2b&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Adenosine+receptor+A2b&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MPLEAQDAVYVALELALAALSVTGNVLVCAAVGTSSALQTPTNYFLVSLAAADVAVGLFAIPFAVTISLGFCTDFHSCLFLACFVLVLTQSSIFSLLAVAVDRYLAVRVPLRYKSLVTGARARGVIAALWVLAFGIGLTPFLGWNDRKIATNCTEPGDAATNVSCCLIRCLFENVVPMSYMVYFNFFGCVLPPLLIMLVIYVKIFLVACRQLQRTELMDHSRTVLQREIHAAKSLALIVGIFALCWLPVHTINCASLFQPTWAKVKPKWAINTAILLSHANSAVNPIVYAYRNRDFRYTFHKIISRYILCRTHILKSGEGQVGSQPTLQLGL Adenosine receptor A2b AA2BR_BOVIN Q1LZD0 184716 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Sodium/nucleoside cotransporter Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000175&target=Sodium%2Fnucleoside+cotransporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Sodium%2Fnucleoside+cotransporter&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MAKSEGRKSASQDTSENGMENPGLELMEVGNLEQGKTLEEVTQGHSLKDGLGHSSLWRRILQPFTKARSFYQRHAGLFKKILLGLLCLAYAAYLLAACILNFRRALALFVITCLVIFILACHFLKKFFAKKSIRCLKPLKNTRLRLWLKRVFMGAAVVGLILWLALDTAQRPEQLISFAGICMFILILFACSKHHSAVSWRTVFWGLGLQFVFGILVIRTEPGFNAFQWLGDQIQIFLAYTVEGSSFVFGDTLVQSVFAFQSLPIIIFFGCVMSILYYLGLVQWVIQKIAWFLQITMGTTAAETLAVAGNIFVGMTEAPLLIRPYLADMTLSEIHAVMTGGFATIAGTVLGAFISFGIDASSLISASVMAAPCALALSKLVYPEVEESKFKSKEGVKLPRGEERNILEAASNGATDAIGLVANVAANLIAFLAVLAFINSTLSWLGEMVDIHGLTFQVICSYVLRPMVFMMGVQWADCPLVAEIVGVKFFINEFVAYQQLSQYKNKRLSGVEEWINGEKQWISVKAEIIATFSLCGFANLTSIGITLGGLTSMVPQRKSDLCKLVVRALFTGACVSFISACMAGILYVPRGAETDCVSFLNTNFTNRTYETYVCCRELFQSTLLNGTNMPSFSGPWQDKESSLRNLAKCCDLYTSTVCA Sodium/nucleoside cotransporter Q91WW8_RAT Q91WW8 184717 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Adenylate cyclase type 3 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000178&target=Adenylate+cyclase+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Adenylate+cyclase+type+3&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MTEDQGFSDPEYSAEYSAEYSVSLPSDPDRGVGRTHEISVRNSGSCLCLPRFMRLTFVPESLENLYQTYFKRQRHETLLVLVVFAALFDCYVVVMCAVVFSSDKLAPLMVAGVGLVLDIILFVLCKKGLLPDRVSRKVVPYLLWLLITAQIFSYLGLNFSRAHAASDTVGWQAFFVFSFFITLPLSLSPIVIISVVSCVVHTLVLGVTVAQQQQDELEGMQLLREILANVFLYLCAIIVGIMSYYMADRKHRKAFLEARQSLEVKMNLEEQSQQQENLMLSILPKHVADEMLKDMKKDESQKDQQQFNTMYMYRHENVSILFADIVGFTQLSSACSAQELVKLLNELFARFDKLAAKYHQLRIKILGDCYYCICGLPDYREDHAVCSILMGLAMVEAISYVREKTKTGVDMRVGVHTGTVLGGVLGQKRWQYDVWSTDVTVANKMEAGGIPGRVHISQSTMDCLKGEFDVEPGDGGSRCDYLDEKGIETYLIIASKPEVKKTAQNGLNGSALPNGAPASKPSSPALIETKEPNGSAHASGSTSEEAEEQEAQADNPSFPNPRRRLRLQDLADRVVDASEDEHELNQLLNEALLERESAQVVKKRNTFLLTMRFMDPEMETRYSVEKEKQSGAAFSCSCVVLFCTAMVEILIDPWLMTNYVTFVVGEVLLLILTICSMAAIFPRAFPKKLVAFSSWIDRTRWARNTWAMLAIFILVMANVVDMLSCLQYYMGPYNVTTGIELDGGCMENPKYYNYVAVLSLIATIMLVQVSHMVKLTLMLLVTGAVTAINLYAWCPVFDEYDHKRFQEKDSPMVALEKMQVLSTPGLNGTDSRLPLVPSKYSMTVMMFVMMLSFYYFSRHVEKLARTLFLWKIEVHDQKERVYEMRRWNEALVTNMLPEHVARHFLGSKKRDEELYSQSYDEIGVMFASLPNFADFYTEESINNGGIECLRFLNEIISDFDSLLDNPKFRVITKIKTIGSTYMAASGVTPDVNTNGFTSSSKEEKSDKERWQHLADLADFALAMKDTLTNINNQSFNNFMLRIGMNKGGVLAGVIGARKPHYDIWGNTVNVASRMESTGVMGNIQVVEETQVILREYGFRFVRRGPIFVKGKGELLTFFLKGRDRPAAFPNGSSVTLPHQVVDNP Adenylate cyclase type 3 ADCY3_RAT P21932 184718 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Alpha-1A adrenergic receptor Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6432&target=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Alpha-1A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV Alpha-1A adrenergic receptor ADA1A_RAT P43140 184719 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Alpha-1B adrenergic receptor Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3629&target=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Alpha-1B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF Alpha-1B adrenergic receptor ADA1B_RAT P15823 Q63215 184720 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Alpha-2A adrenergic receptor Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9124&target=Alpha-2A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Alpha-2A+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MFRQEQPLAEGSFAPMGSLQPDAGNASWNGTEAPGGGARATPYSLQVTLTLVCLAGLLMLLTVFGNVLVIIAVFTSRALKAPQNLFLVSLASADILVATLVIPFSLANEVMGYWYFGKAWCEIYLALDVLFCTSSIVHLCAISLDRYWSITQAIEYNLKRTPRRIKAIIITVWVISAVISFPPLISIEKKGGGGGPQPAEPRCEINDQKWYVISSCIGSFFAPCLIMILVYVRIYQIAKRRTRVPPSRRGPDAVAAPPGGTERRPNGLGPERSAGPGGAEAEPLPTQLNGAPGEPAPAGPRDTDALDLEESSSSDHAERPPGPRRPERGPRGKGKARASQVKPGDSLPRRGPGATGIGTPAAGPGEERVGAAKASRWRGRQNREKRFTFVLAVVIGVFVVCWFPFFFTYTLTAVGCSVPRTLFKFFFWFGYCNSSLNPVIYTIFNHDFRRAFKKILCRGDRKRIV 7W7E,7W6P,7EJK,7EJA,7EJ8,7EJ0 Alpha-2A adrenergic receptor ADA2A_HUMAN P08913 B0LPF6 Q2I8G2 Q2XN99 Q86TH8 Q9BZK1 184721 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Alpha-2B adrenergic receptor Mus musculus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000231&target=Alpha-2B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Alpha-2B+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MVHQEPYSVQATAAIASAITFLILFTIFGNALVILAVLTSRSLRAPQNLFLVSLAAADILVATLIIPFSLANELLGYWYFWRAWCEVYLALDVLFCTSSIVHLCAISLDRYWAVSRALEYNSKRTPRRIKCIILTVWLIAAVISLPPLIYKGDQRPEPHGLPQCELNQEAWYILASSIGSFFAPCLIMILVYLRIYVIAKRSHCRGLGAKRGSGEGESKKPRPGPAAGGVPASAKVPTLVSPLSSVGEANGHPKPPREKEEGETPEDPEARALPPNWSALPRSVQDQKKGTSGATAEKGAEEDEEEVEECEPQTLPASPASVFNPPLQQPQTSRVLATLRGQVLLSKNVGVASGQWWRRRTQLSREKRFTFVLAVVIGVFVVCWFPFFFSYSLGAICPQHCKVPHGLFQFFFWIGYCNSSLNPVIYTIFNQDFRRAFRRILCRQWTQTGW Alpha-2B adrenergic receptor ADA2B_MOUSE P30545 F8VQ23 184722 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Beta-1 adrenergic receptor Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5366&target=Beta-1+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Beta-1+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MGAGALALGASEPCNLSSAAPLPDGAATAARLLVLASPPASLLPPASEGSAPLSQQWTAGMGLLLALIVLLIVVGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITLPFRYQSLLTRARARALVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIMAFVYLRVFREAQKQVKKIDSCERRFLTGPPRPPSPAPSPSPGPPRPADSLANGRSSKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRDLVPDRLFVFFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAACRRRAAHGDRPRASGCLARAGPPPSPGAPSDDDDDDAGATPPARLLEPWAGCNGGTTTVDSDSSLDEPGRQGFSSESKV Beta-1 adrenergic receptor ADRB1_RAT P18090 184723 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Beta-2 adrenergic receptor Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50002638&target=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Beta-2+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MEPHGNDSDFLLAPNGSRAPGHDITQERDEAWVVGMAILMSVIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMKMWNFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYVAITSPFKYQSLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHKQAIDCYAKETCCDFFTNQAYAIASSIVSFYVPLVVMVFVYSRVFQVAKRQLQKIDKSEGRFHAQNLSQVEQDGRSGHGLRSSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIRANLIPKEVYILLNWLGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSSSKTYGNGYSSNSNGRTDYTGEQSAYQLGQEKENELLCEEAPGMEGFVNCQGTVPSLSIDSQGRNCNTNDSPL 8UO1,8W1V,3KJ6 Beta-2 adrenergic receptor ADRB2_RAT P10608 Q6LCR3 184724 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Voltage-dependent N-type calcium channel subunit alpha-1B Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000313&target=Voltage-dependent+N-type+calcium+channel+subunit+alpha-1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Voltage-dependent+N-type+calcium+channel+subunit+alpha-1B&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MVRFGDELGGRYGGTGGGERARGGGAGGAGGPGQGGLPPGQRVLYKQSIAQRARTMALYNPIPVKQNCFTVNRSLFVFSEDNVVRKYAKRITEWPPFEYMILATIIANCIVLALEQHLPDGDKTPMSERLDDTEPYFIGIFCFEAGIKIIALGFVFHKGSYLRNGWNVMDFVVVLTEILATAGTDFDLRTLRAVRVLRPLKLVSGIPSLQVVLKSIMKAMVPLLQIGLLLFFAILMFAIIGLEFYMGKFHKACFPNSTDAEPVGDFPCGKEAPARLCDSDTECREYWPGPNFGITNFDNILFAILTVFQCITMEGWTDILYNTNDAAGNTWNWLYFIPLIIIGSFFMLNLVLGVLSGEFAKERERVENRRAFLKLRRQQQIERELNGYLEWIFKAEEVMLAEEDKNAEEKSPLDAVLKRAATKKSRNDLIHAEEGEDRFVDLCAAGSPFARASLKSGKTESSSYFRRKEKMFRFLIRRMVKAQSFYWVVLCVVALNTLCVAMVHYNQPQRLTTALYFAEFVFLGLFLTEMSLKMYGLGPRSYFRSSFNCFDFGVIVGSIFEVVWAAIKPGTSFGISVLRALRLLRIFKVTKYWNSLRNLVVSLLNSMKSIISLLFLLFLFIVVFALLGMQLFGGQFNFQDETPTTNFDTFPAAILTVFQILTGEDWNAVMYHGIESQGGVSKGMFSSFYFIVLTLFGNYTLLNVFLAIAVDNLANAQELTKDEEEMEEAANQKLALQKAKEVAEVSPMSAANISIAARQQNSAKARSVWEQRASQLRLQNLRASCEALYSEMDPEERLRYASTRHVRPDMKTHMDRPLVVEPGRDGLRGPAGNKSKPEGTEATEGADPPRRHHRHRDRDKTSASTPAGGEQDRTDCPKAESTETGAREERARPRRSHSKEAPGADTQVRCERSRRHHRRGSPEEATEREPRRHRAHRHAQDSSKEGKEGTAPVLVPKGERRARHRGPRTGPRETENSEEPTRRHRAKHKVPPTLEPPEREVAEKESNVVEGDKETRNHQPKEPRCDLEAIAVTGVGSLHMLPSTCLQKVDEQPEDADNQRNVTRMGSQPSDPSTTVHVPVTLTGPPGEATVVPSANTDLEGQAEGKKEAEADDVLRRGPRPIVPYSSMFCLSPTNLLRRFCHYIVTMRYFEMVILVVIALSSIALAAEDPVRTDSFRNNALKYMDYIFTGVFTFEMVIKMIDLGLLLHPGAYFRDLWNILDFIVVSGALVAFAFSSFMGGSKGKDINTIKSLRVLRVLRPLKTIKRLPKLKAVFDCVVNSLKNVLNILIVYMLFMFIFAVIAVQLFKGKFFYCTDESKELERDCRGQYLDYEKEEVEAQPRQWKKYDFHYDNVLWALLTLFTVSTGEGWPMVLKHSVDATYEEQGPSPGFRMELSIFYVVYFVVFPFFFVNIFVALIIITFQEQGDKVMSECSLEKNERACIDFAISAKPLTRYMPQNKQSFQYKTWTFVVSPPFEYFIMAMIALNTVVLMMKFYDAPYEYELMLKCLNIVFTSMFSLECILKIIAFGVLNYFRDAWNVFDFVTVLGSITDILVTEIANNFINLSFLRLFRAARLIKLCRQGYTIRILLWTFVQSFKALPYVCLLIAMLFFIYAIIGMQVFGNIALDDGTSINRHNNFRTFLQALMLLFRSATGEAWHEIMLSCLGNRACDPHANASECGSDFAYFYFVSFIFLCSFLMLNLFVAVIMDNFEYLTRDSSILGPHHLDEFIRVWAEYDPAACGRISYNDMFEMLKHMSPPLGLGKKCPARVAYKRLVRMNMPISNEDMTVHFTSTLMALIRTALEIKLAPAGTKQHQCDAELRKEISSVWANLPQKTLDLLVPPHKPDEMTVGKVYAALMIFDFYKQNKTTRDQTHQAPGGLSQMGPVSLFHPLKATLEQTQPAVLRGARVFLRQKSATSLSNGGAIQTQESGIKESLSWGTQRTQDVLYEARAPLERGHSAEIPVGQPGALAVDVQMQNMTLRGPDGEPQPGLESQGRAASMPRLAAETQPAPNASPMKRSISTLAPRPHGTQLCNTVLDRPPPSQVSHHHHHRCHRRRDKKQRSLEKGPSLSVDTEGAPSTAAGSGLPHGEGSTGCRRERKQERGRSQERRQPSSSSSEKQRFYSCDRFGSREPPQPKPSLSSHPISPTAALEPGPHPQGSGSVNGSPLMSTSGASTPGRGGRRQLPQTPLTPRPSITYKTANSSPVHFAEGQSGLPAFSPGRLSRGLSEHNALLQKEPLSQPLASGSRIGSDPYLGQRLDSEASAHNLPEDTLTFEEAVATNSGRSSRTSYVSSLTSQSHPLRRVPNGYHCTLGLSTGVRARHSYHHPDQDHWC 4DEX,2LCM Voltage-dependent N-type calcium channel subunit alpha-1B CAC1B_RAT Q02294 184725 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Olfactory receptor 145 Mus musculus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000317&target=Olfactory+receptor+145&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Olfactory+receptor+145&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MATENASVPEFILAGLTDQPGLRMPLFFLFLGFYMVTMVGNLGLITLIGLNSHLHTPMYFFLFNLSLIDFCYSTVITPKMLVSFVSKKNIISYSGCMTQLFFFLFFVVSESFILSAMAYDRYVAICNPLMYTVTMSPQVCLLLLLGVYVMGFAGAMAHTAFMVKLTFCADKLVNHYMCDILPLLERSCTSTYVNELVVFIVVGIDIGVPTVTIFISYALILSSILRISSTEGRSKAFSTCSSHIIAVSLFFGSGAFMYLKPSSLLPMNQGKVSSLFYTIVVPMLNPLIYSLRNKDVKVALRKTLSRSSFS Olfactory receptor 8B8 OR8B8_MOUSE Q60882 Q9EQB0 184726 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Gastrin/cholecystokinin type B receptor Mus musculus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000348&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MDLLKLNRSLQGPGPGSGSSLCRPGVSLLNSSSAGNLSCETPRIRGTGTRELELTIRITLYAVIFLMSVGGNVLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLNLAAIALERYSAICRPLQARVWQTRSHAARVILATWLLSGLLMVPYPVYTVVQPVGPRILQCMHLWPSERVQQMWSVLLLILLFFIPGVVMAVAYGLISRELYLGLRFDGDNDSETQSRVRNQGGLPGGAAAPGPVHQNGGCRHVTSLTGEDSDGCYVQLPRSRLEMTTLTTPTTGPGPGPRPNQAKLLAKKRVVRMLLVIVLLFFVCWLPVYSANTWRAFDGPGARRALAGAPISFIHLLSYTSACANPLVYCFMHRRFRQACLDTCARCCPRPPRARPRPLPDEDPPTPSIASLSRLSYTTISTLGPG Gastrin/cholecystokinin type B receptor GASR_MOUSE P56481 184727 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Gastrin/cholecystokinin type B receptor Mus musculus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000348&target=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Gastrin%2Fcholecystokinin+type+B+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MDLLKLNRSLQGPGPGSGSSLCRPGVSLLNSSSAGNLSCETPRIRGTGTRELELTIRITLYAVIFLMSVGGNVLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLNLAAIALERYSAICRPLQARVWQTRSHAARVILATWLLSGLLMVPYPVYTVVQPVGPRILQCMHLWPSERVQQMWSVLLLILLFFIPGVVMAVAYGLISRELYLGLRFDGDNDSETQSRVRNQGGLPGGAAAPGPVHQNGGCRHVTSLTGEDSDGCYVQLPRSRLEMTTLTTPTTGPGPGPRPNQAKLLAKKRVVRMLLVIVLLFFVCWLPVYSANTWRAFDGPGARRALAGAPISFIHLLSYTSACANPLVYCFMHRRFRQACLDTCARCCPRPPRARPRPLPDEDPPTPSIASLSRLSYTTISTLGPG Gastrin/cholecystokinin type B receptor GASR_MOUSE P56481 184729 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Muscarinic acetylcholine receptor M1 Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10062&target=Muscarinic+acetylcholine+receptor+M1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Muscarinic+acetylcholine+receptor+M1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVNNYFLLSLACADLIIGTFSMNLYTTYLLMGHWALGTLACDLWLALDYVASNASVMNLLLISFDRYFSVTRPLSYRAKRTPRRAALMIGLAWLVSFVLWAPAILFWQYLVGERTVLAGQCYIQFLSQPIITFGTAMAAFYLPVTVMCTLYWRIYRETENRARELAALQGSETPGKGGGSSSSSERSQPGAEGSPETPPGRCCRCCRAPRLLQAYSWKEEEEEDEGSMESLTSSEGEEPGSEVVIKMPMVDPEAQAPTKQPPRSSPNTVKRPTKKGRDRAGKGQKPRGKEQLAKRKTFSLVKEKKAARTLSAILLAFILTWTPYNIMVLVSTFCKDCVPETLWELGYWLCYVNSTINPMCYALCNKAFRDTFRLLLLCRWDKRRWRKIPKRPGSVHRTPSRQC Muscarinic acetylcholine receptor M1 ACM1_HUMAN P11229 Q96RH1 184730 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Muscarinic acetylcholine receptor M2 Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9678&target=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Muscarinic+acetylcholine+receptor+M2&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR 6U1N,5ZKC,5ZKB,5ZK3,5YC8 Muscarinic acetylcholine receptor M2 ACM2_HUMAN P08172 Q4VBK6 Q9P1X9 184731 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE D(1A) dopamine receptor Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000438&target=D%281A%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=D%281A%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MAPNTSTMDEAGLPAERDFSFRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPWKAVAEIAGFWPLGPFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFQYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTWPLDGNFTSLEDTEDDNCDTRLSRTYAISSSLISFYIPVAIMIVTYTSIYRIAQKQIRRISALERAAVHAKNCQTTAGNGNPVECAQSESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFISNCMVPFCGSEETQPFCIDSITFDVFVWFGWANSSLNPIIYAFNADFQKAFSTLLGCYRLCPTTNNAIETVSINNNGAVVFSSHHEPRGSISKDCNLVYLIPHAVGSSEDLKKEEAGGIAKPLEKLSPALSVILDYDTDVSLEKIQPVTHSGQHST 7JOZ D(1A) dopamine receptor DRD1_RAT P18901 P21669 184732 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE D(2) dopamine receptor Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 8IRS,7JVR,8U02,8TZQ D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 N/A A0A024R3C5 184733 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Sodium-dependent dopamine transporter Homo sapiens 1451 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2272&target=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV 9EO4,8Y2F,8Y2E,8Y2C,8Y2D Sodium-dependent dopamine transporter SC6A3_HUMAN Q01959 A2RUN4 Q14996 184734 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3 SNPPWIUOZRMYNY-UHFFFAOYSA-N 50048392 BUPROPION HYDROCHLORIDE::CHEMBL894::2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one::BUPROPION::US9944618, Compound ID No. 176 Sodium-dependent dopamine transporter Homo sapiens 562 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50048392 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2272&target=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50048392&enzyme=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search 444 103978858 CHEMBL894 DB01156 C06860 1 MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV 9EO4,8Y2F,8Y2E,8Y2C,8Y2D Sodium-dependent dopamine transporter SC6A3_HUMAN Q01959 A2RUN4 Q14996 184735 CNCCCN1c2ccccc2CCc3c1cccc3 InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3 HCYAFALTSJYZDH-UHFFFAOYSA-N 35229 Desmethylimipramine::3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1-amine::monodemethylimipramine::Desipramin::5-(gamma-methylaminopropyl)iminodibenzyl::norimipramine::CHEMBL72::DESIPRAMINE HYDROCHLORIDE::demethylimipramine::N-(3-methylaminopropyl)iminobibenzyl::DMI::Desipramine::US9944618, Compound ID No. 174 Sodium-dependent dopamine transporter Homo sapiens >10000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2272&target=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=35229&enzyme=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search DSM 7Q19,2QJU,7Q2N,7Q2O,7Q2P,8HFI,8WGR,2QB4 2995 85753308 CHEMBL72 DB01151 C06943 1 MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV 9EO4,8Y2F,8Y2E,8Y2C,8Y2D Sodium-dependent dopamine transporter SC6A3_HUMAN Q01959 A2RUN4 Q14996 184736 CNCC[C@H](c1ccccc1)Oc2ccc(cc2)C(F)(F)F InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 30130 Prozac::cid_62857::Fluoxetin::CHEMBL41::CHEMBL1201082::Fluoxetine::US9120771, Fluoxetine Sodium-dependent dopamine transporter Homo sapiens 4752 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2272&target=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=30130&enzyme=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search RFX 4MM8,3GWV 3386 85147891 CHEMBL1201082CHEMBL41 DB00472 1 MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV 9EO4,8Y2F,8Y2E,8Y2C,8Y2D Sodium-dependent dopamine transporter SC6A3_HUMAN Q01959 A2RUN4 Q14996 184737 CN(C)CCCN1c2ccccc2CCc3c1cccc3 InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3 BCGWQEUPMDMJNV-UHFFFAOYSA-N 50010859 CHEMBL11::Imipramin::IMIPRAMINE HYDROCHLORIDE::IMIPRAMINE PAMOATE Sodium-dependent dopamine transporter Homo sapiens >10000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50010859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2272&target=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50010859&enzyme=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search IXX 2Q72,7LWD,6G9B 3696 103923605 CHEMBL11 DB00458 C07049 1 MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV 9EO4,8Y2F,8Y2E,8Y2C,8Y2D Sodium-dependent dopamine transporter SC6A3_HUMAN Q01959 A2RUN4 Q14996 184738 COC(=O)[C@H]([C@@H]1CCCCN1)c1ccccc1 InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3 DUGOZIWVEXMGBE-UHFFFAOYSA-N 50050098 CHEMBL542556::METHYLPHENIDATE::(S)-Phenyl-(S)-piperidin-2-yl-acetic acid methyl ester; hydrochloride Sodium-dependent dopamine transporter Homo sapiens 34 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50050098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2272&target=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50050098&enzyme=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search 10657292 103947285 CHEMBL542556 C07196 1 MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV 9EO4,8Y2F,8Y2E,8Y2C,8Y2D Sodium-dependent dopamine transporter SC6A3_HUMAN Q01959 A2RUN4 Q14996 184739 CN1Cc2c(cccc2N)[C@@H](C1)c3ccccc3 InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3 XXPANQJNYNUNES-UHFFFAOYSA-N 50005548 (+/-)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine (Nomifensine)::2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::CHEMBL273575::(+)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::(Nomifensine) 2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-8-amine::NOMIFENSINE2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::(-)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine(Nomifensine)::NOMIFENSINE Sodium-dependent dopamine transporter Homo sapiens 53 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50005548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2272&target=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50005548&enzyme=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search A1LX5 8Y91 4528 103919027 CHEMBL273575 DB04821 1 MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV 9EO4,8Y2F,8Y2E,8Y2C,8Y2D Sodium-dependent dopamine transporter SC6A3_HUMAN Q01959 A2RUN4 Q14996 184740 CCOc1ccccc1O[C@@H](c2ccccc2)[C@@H]3CNCCO3 InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3 CBQGYUDMJHNJBX-UHFFFAOYSA-N 35226 Vestra::Reboxetine::(S,S)-reboxetine Sodium-dependent dopamine transporter Homo sapiens >10000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2272&target=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=35226&enzyme=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search A1D9Y 8ZP1 65856 85753305 DB00234 1 MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV 9EO4,8Y2F,8Y2E,8Y2C,8Y2D Sodium-dependent dopamine transporter SC6A3_HUMAN Q01959 A2RUN4 Q14996 184741 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Sodium-dependent dopamine transporter Homo sapiens 1451 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2272&target=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Sodium-dependent+dopamine+transporter&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELALGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQLTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSVDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSSGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGIDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAAGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKDRELVDRGEVRQFTLRHWLKV 9EO4,8Y2F,8Y2E,8Y2C,8Y2D Sodium-dependent dopamine transporter SC6A3_HUMAN Q01959 A2RUN4 Q14996 184742 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Gamma-aminobutyric acid receptor subunit alpha-1 Bos taurus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000529&target=Gamma-aminobutyric+acid+receptor+subunit+alpha-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Gamma-aminobutyric+acid+receptor+subunit+alpha-1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MKKSPGLSDYLWAWTLFLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLLDGYDNRLRPGLGERVTEVKTDIFVTSFGPVSDHDMEYTIDVFFRQSWKDERLKFKGPMTVLRLNNLMASKIWTPDTFFHNGKKSVAHNMTMPNKLLRITEDGTLLYTMRLTVRAECPMHLEDFPMDAHACPLKFGSYAYTRAEVVYEWTREPARSVVVAEDGSRLNQYDLLGQTVDSGIVQSSTGEYVVMTTHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLNRESVPARTVFGVTTVLTMTTLSISARNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVNYFTKRGYAWDGKSVVPEKPKKVKDPLIKKNNTYAPTATSYTPNLARGDPGLATIAKSATIEPKEVKPETKPPEPKKTFNSVSKIDRLSRIAFPLLFGIFNLVYWATYLNREPQLKAPTPHQ 9FGH,9FGG,9FGF,9FGD,9FGC,9FGB,9FGA,9FG9,9FG8,9FG7,9FG6,9FG5,9FG4,9EQG,6I53,6HUP,6HUO,6HUK,6HUJ,9CXD,9CXC,9CXB,9CX7,9CTV,9CTP,9CTJ,9CT0,9CSB,9CRV,9CRS,6HUG,9H9E,8PET,9FAT,9FAM,9FAK,9FAJ,9FAS,9FAQ,9FAP,9DRX,8VRN,8VQY,8SID,8SI9,8SGO,8DD3,8DD2,7T0Z,7T0W,6X40,6X3Z,6X3X,6X3W,6X3V,6X3U,6X3T,6X3S,6D6U,6D6T,9FG3,9FG2,9FG1,9FFZ,9FFY,9FFX,9FFW,9FFV,9FFU,9FFT,9FFS,9FFR,9FFQ,9FFP,9FFO,9FFN,9FFM,9FFL,7PC0,7PBZ,7PBD,9FG0 Gamma-aminobutyric acid receptor subunit alpha-1 GBRA1_BOVIN P08219 Q29RI5 184743 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Gamma-aminobutyric acid receptor subunit alpha-1 Bos taurus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000529&target=Gamma-aminobutyric+acid+receptor+subunit+alpha-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Gamma-aminobutyric+acid+receptor+subunit+alpha-1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MKKSPGLSDYLWAWTLFLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLLDGYDNRLRPGLGERVTEVKTDIFVTSFGPVSDHDMEYTIDVFFRQSWKDERLKFKGPMTVLRLNNLMASKIWTPDTFFHNGKKSVAHNMTMPNKLLRITEDGTLLYTMRLTVRAECPMHLEDFPMDAHACPLKFGSYAYTRAEVVYEWTREPARSVVVAEDGSRLNQYDLLGQTVDSGIVQSSTGEYVVMTTHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLNRESVPARTVFGVTTVLTMTTLSISARNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVNYFTKRGYAWDGKSVVPEKPKKVKDPLIKKNNTYAPTATSYTPNLARGDPGLATIAKSATIEPKEVKPETKPPEPKKTFNSVSKIDRLSRIAFPLLFGIFNLVYWATYLNREPQLKAPTPHQ 9FGH,9FGG,9FGF,9FGD,9FGC,9FGB,9FGA,9FG9,9FG8,9FG7,9FG6,9FG5,9FG4,9EQG,6I53,6HUP,6HUO,6HUK,6HUJ,9CXD,9CXC,9CXB,9CX7,9CTV,9CTP,9CTJ,9CT0,9CSB,9CRV,9CRS,6HUG,9H9E,8PET,9FAT,9FAM,9FAK,9FAJ,9FAS,9FAQ,9FAP,9DRX,8VRN,8VQY,8SID,8SI9,8SGO,8DD3,8DD2,7T0Z,7T0W,6X40,6X3Z,6X3X,6X3W,6X3V,6X3U,6X3T,6X3S,6D6U,6D6T,9FG3,9FG2,9FG1,9FFZ,9FFY,9FFX,9FFW,9FFV,9FFU,9FFT,9FFS,9FFR,9FFQ,9FFP,9FFO,9FFN,9FFM,9FFL,7PC0,7PBZ,7PBD,9FG0 Gamma-aminobutyric acid receptor subunit alpha-1 GBRA1_BOVIN P08219 Q29RI5 184744 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Gamma-aminobutyric acid (GABA) B receptor 1 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2457&target=Gamma-aminobutyric+acid+%28GABA%29+B+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Gamma-aminobutyric+acid+%28GABA%29+B+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MLLLLLVPLFLRPLGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQVKAINFLPVDYEIEYVCRGEREVVGPKVRKCLANGSWTDMDTPSRCVRICSKSYLTLENGKVFLTGGDLPALDGARVEFRCDPDFHLVGSSRSVCSQGQWSTPKPHCQVNRTPHSERRAVYIGALFPMSGGWPGGQACQPAVEMALEDVNSRRDILPDYELKLIHHDSKCDPGQATKYLYELLYNDPIKIILMPGCSSVSTLVAEAARMWNLIVLSYGSSSPALSNRQRFPTFFRTHPSATLHNPTRVKLFEKWGWKKIATIQQTTEVFTSTLDDLEERVKEAGIEITFRQSFFSDPAVPVKNLKRQDARIIVGLFYETEARKVFCEVYKERLFGKKYVWFLIGWYADNWFKTYDPSINCTVEEMTEAVEGHITTEIVMLNPANTRSISNMTSQEFVEKLTKRLKRHPEETGGFQEAPLAYDAIWALALALNKTSGGGGRSGVRLEDFNYNNQTITDQIYRAMNSSSFEGVSGHVVFDASGSRMAWTLIEQLQGGSYKKIGYYDSTKDDLSWSKTDKWIGGSPPADQTLVIKTFRFLSQKLFISVSVLSSLGIVLAVVCLSFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDGYHIGRSQFPFVCQARLWLLGLGFSLGYGSMFTKIWWVHTVFTKKEEKKEWRKTLEPWKLYATVGLLVGMDVLTLAIWQIVDPLHRTIETFAKEEPKEDIDVSILPQLEHCSSKKMNTWLGIFYGYKGLLLLLGIFLAYETKSVSTEKINDHRAVGMAIYNVAVLCLITAPVTMILSSQQDAAFAFASLAIVFSSYITLVVLFVPKMRRLITRGEWQSETQDTMKTGSSTNNNEEEKSRLLEKENRELEKIIAEKEERVSELRHQLQSRQQLRSRRHPPTPPDPSGGLPRGPSEPPDRLSCDGSRVHLLYK 6HKC,1SS2,1SRZ,4PAS Gamma-aminobutyric acid type B receptor subunit 1 Q6MFX8_RAT Q6MFX8 A0A0A0MY30 184745 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Gamma-aminobutyric acid receptor subunit alpha-1 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10421&target=Gamma-aminobutyric+acid+receptor+subunit+alpha-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Gamma-aminobutyric+acid+receptor+subunit+alpha-1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MKKSRGLSDYLWAWTLILSTLSGRSYGQPSQDELKDNTTVFTRILDRLLDGYDNRLRPGLGERVTEVKTDIFVTSFGPVSDHDMEYTIDVFFRQSWKDERLKFKGPMTVLRLNNLMASKIWTPDTFFHNGKKSVAHNMTMPNKLLRITEDGTLLYTMRLTVRAECPMHLEDFPMDAHACPLKFGSYAYTRAEVVYEWTREPARSVVVAEDGSRLNQYDLLGQTVDSGIVQSSTGEYVVMTTHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLNRESVPARTVFGVTTVLTMTTLSISARNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVNYFTKRGYAWDGKSVVPEKPKKVKDPLIKKNNTYAPTATSYTPNLARGDPGLATIAKSATIEPKEVKPETKPPEPKKTFNSVSKIDRLSRIAFPLLFGIFNLVYWATYLNREPQLKAPTPHQ 8G5H,8G5G,8G5F,8G4X,8G4O,8G4N,8FOI,9CXD,9CXC,9CXB,9CX7,9CTV,9CTP,9CTJ,9CT0,9CSB,9CRV,9CRS,6HUG,9H9E,8PET,9FAT,9FAM,9FAK,9FAJ,9FAS,9FAQ,9FAP,6DW1,6DW0,9FG3,9FG2,9FG1,9FFZ,9FFY,9FFX,9FFW,9FFV,9FFU,9FFT,9FFS,9FFR,9FFQ,9FFP,9FFO,9FFN,9FFM,9FFL,7PC0,7PBZ,7PBD,9DRX,8VRN,8VQY,8SID,8SI9,8SGO,8DD3,8DD2,7T0Z,7T0W,6X40,6X3Z,6X3X,6X3W,6X3V,6X3U,6X3T,6X3S,6D6U,6D6T,9FG0 Gamma-aminobutyric acid receptor subunit alpha-1 GBRA1_RAT P62813 P18504 Q53YK4 184746 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Glutamate receptor 3 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000616&target=Glutamate+receptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Glutamate+receptor+3&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MGQSVLRAVFFLVLGLLGHSHGGFPNTISIGGLFMRNTVQEHSAFRFAVQLYNTNQNTTEKPFHLNYHVDHLDSSNSFSVTNAFCSQFSRGVYAIFGFYDQMSMNTLTSFCGALHTSFVTPSFPTDADVQFVIQMRPALKGAILSLLSYYKWEKFVYLYDTERGFSVLQAIMEAAVQNNWQVTARSVGNIKDVQEFRRIIEEMDRRQEKRYLIDCEVERINTILEQVVILGKHSRGYHYMLANLGFTDILLERVMHGGANITGFQIVNNENPMVQQFIQRWVRLDEREFPEAKNAPLKYTSALTHDAILVIAEAFRYLRRQRVDVSRRGSAGDCLANPAVPWSQGIDIERALKMVQVQGMTGNIQFDTYGRRTNYTIDVYEMKVSGSRKAGYWNEYERFVPFSDQQISNDSSSSENRTIVVTTILESPYVMYKKNHEQLEGNERYEGYCVDLAYEIAKHVRIKYKLSIVGDGKYGARDPETKIWNGMVGELVYGRADIAVAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFLDPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHLEDNNEEPRDPQSPPDPPNEFGIFNSLWFSLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAEDLAKQTEIAYGTLDSGSTKEFFRRSKIAVYEKMWSYMKSAEPSVFTKTTADGVARVRKSKGKFAFLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGVATPKGSALGNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGSGGGDSKDKTSALSLSNVAGVFYILVGGLGLAMMVALIEFCYKSRAESKRMKLTKNTQNFKPAPATNTQNYATYREGYNVYGTESVKI Glutamate receptor 3 GRIA3_RAT P19492 184747 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Glutamate receptor ionotropic, kainate 1 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000629&target=Glutamate+receptor+ionotropic%2C+kainate+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Glutamate+receptor+ionotropic%2C+kainate+1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MERSTVLIQPGLWTRDTSWTLLYFLCYILPQTSPQVLRIGGIFETVENEPVNVEELAFKFAVTSINRNRTLMPNTTLTYDIQRINLFDSFEASRRACDQLALGVAALFGPSHSSSVSAVQSICNALEVPHIQTRWKHPSVDSRDLFYINLYPDYAAISRAVLDLVLYYNWKTVTVVYEDSTGLIRLQELIKAPSRYNIKIKIRQLPPANKDAKPLLKEMKKSKEFYVIFDCSHETAAEILKQILFMGMMTEYYHYFFTTLDLFALDLELYRYSGVNMTGFRKLNIDNPHVSSIIEKWSMERLQAPPRPETGLLDGMMTTEAALMYDAVYMVAIASHRASQLTVSSLQCHRHKPCALGPRFMNLIKEARWDGLTGRITFNKTDGLRKDFDLDIISLKEEGTEKASGEVSKHLYKVWKKIGIWNSNSGLNMTDGNRDRSNNITDSLANRTLIVTTILEEPYVMYRKSDKPLYGNDRFEAYCLDLLKELSNILGFLYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYVLLACLGVSCVLFVIARFTPYEWYNPHPCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQSALVKNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPEEDSKEASALGVENIGGIFIVLAAGLVLSVFVAIGEFLYKSRKNNDVEQKGKSSRLRFYFRNKVRFHGSKKESLGVEKCLSFNAIMEELGISLKNQKKLKKKSRTKGKSSFTSILTCHQRRTQRKETVA Glutamate receptor ionotropic, kainate 1 GRIK1_RAT P22756 184748 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000630&target=Glutamate+receptor+ionotropic%2C+NMDA+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Glutamate+receptor+ionotropic%2C+NMDA+1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MSTMHLLTFALLFSCSFARAACDPKIVNIGAVLSTRKHEQMFREAVNQANKRHGSWKIQLNATSVTHKPNAIQMALSVCEDLISSQVYAILVSHPPTPNDHFTPTPVSYTAGFYRIPVLGLTTRMSIYSDKSIHLSFLRTVPPYSHQSSVWFEMMRVYNWNHIILLVSDDHEGRAAQKRLETLLEERESKAEKVLQFDPGTKNVTALLMEARELEARVIILSASEDDAATVYRAAAMLNMTGSGYVWLVGEREISGNALRYAPDGIIGLQLINGKNESAHISDAVGVVAQAVHELLEKENITDPPRGCVGNTNIWKTGPLFKRVLMSSKYADGVTGRVEFNEDGDRKFANYSIMNLQNRKLVQVGIYNGTHVIPNDRKIIWPGGETEKPRGYQMSTRLKIVTIHQEPFVYVKPTMSDGTCKEEFTVNGDPVKKVICTGPNDTSPGSPRHTVPQCCYGFCIDLLIKLARTMNFTYEVHLVADGKFGTQERVNNSNKKEWNGMMGELLSGQADMIVAPLTINNERAQYIEFSKPFKYQGLTILVKKEIPRSTLDSFMQPFQSTLWLLVGLSVHVVAVMLYLLDRFSPFGRFKVNSEEEEEDALTLSSAMWFSWGVLLNSGIGEGAPRSFSARILGMVWAGFAMIIVASYTANLAAFLVLDRPEERITGINDPRLRNPSDKFIYATVKQSSVDIYFRRQVELSTMYRHMEKHNYESAAEAIQAVRDNKLHAFIWDSAVLEFEASQKCDLVTTGELFFRSGFGIGMRKDSPWKQNVSLSILKSHENGFMEDLDKTWVRYQECDSRSNAPATLTFENMAGVFMLVAGGIVAGIFLIFIEIAYKRHKDARRKQMQLAFAAVNVWRKNLQDRKSGRAEPDPKKKATFRAITSTLASSFKRRRSSKDTSTGGGRGALQNQKDTVLPRRAIEREEGQLQLCSRHRES 8XLK,7YFH,7YFG,8JF7,8USW,6MMX,6MMW,6MMU,6MMT,6MMS,6MMR,6MMP,6MMN,6MMM,6MML,6MMK,6MMJ,6MMI,6MMH,6MMG,6MMB,6MMA,6MM9,9D3C,9D3B,9D3A,9D39,9D38,9D37,9JNN,7YFI,6MMV,8HDK,8UUE,3Q41,9DA9,6UZX,6UZW,6UZR,6UZG,6UZ6,6USV,6USU,6OVE,6OVD,5VIJ,5VII,5VIH,5U8C,5JTY,5I59,5I58,5I57,5I56,5DEX,4NF8,4NF6,4NF5,4NF4,4KFQ,4KCC,2A5T,1Y20,1Y1Z,1Y1M,1PBQ,1PB7 Glutamate receptor ionotropic, NMDA 1 NMDZ1_RAT P35439 Q62646 184749 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Glycine receptor subunit alpha-1 Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000636&target=Glycine+receptor+subunit+alpha-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Glycine+receptor+subunit+alpha-1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MYSFNTLRLYLWETIVFFSLAASKEAEAARSAPKPMSPSDFLDKLMGRTSGYDARIRPNFKGPPVNVSCNIFINSFGSIAETTMDYRVNIFLRQQWNDPRLAYNEYPDDSLDLDPSMLDSIWKPDLFFANEKGAHFHEITTDNKLLRISRNGNVLYSIRITLTLACPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQEQGAVQVADGLTLPQFILKEEKDLRYCTKHYNTGKFTCIEARFHLERQMGYYLIQMYIPSLLIVILSWISFWINMDAAPARVGLGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRQHKELLRFRRKRRHHKSPMLNLFQEDEAGEGRFNFSAYGMGPACLQAKDGISVKGANNSNTTNPPPAPSKSPEEMRKLFIQRAKKIDKISRIGFPMAFLIFNMFYWIIYKIVRREDVHNQ 7MLV,7MLU,8FE1,7U2N,7U2M,7TVI,7TU9,7M6S,7M6R,7M6Q,7M6P,7M6O,7M6N,7M6M,6VM3,6VM2,6VM0,6UD3,6UBT,6UBS,6PM6,6PM5,6PM4,6PM3,6PM2,6PM1,6PM0,6PLZ,6PLY,6PLX,6PLW,6PLV,6PLU,6PLT,6PLS,6PLR,8DN5,8DN4,8DN3,8DN2 Glycine receptor subunit alpha-1 GLRA1_HUMAN P23415 B2R6T3 Q14C77 Q6DJV9 184750 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Glycine receptor subunit alpha-1 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000641&target=Glycine+receptor+subunit+alpha-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Glycine+receptor+subunit+alpha-1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MYSFNTLRFYLWETIVFFSLAASKEADAARSAPKPMSPSDFLDKLMGRTSGYDARIRPNFKGPPVNVSCNIFINSFGSIAETTMDYRVNIFLRQQWNDPRLAYNEYPDDSLDLDPSMLDSIWKPDLFFANEKGAHFHEITTDNKLLRISRNGNVLYSIRITLTLACPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQEQGAVQVADGLTLPQFILKEEKDLRYCTKHYNTGKFTCIEARFHLERQMGYYLIQMYIPSLLIVILSWISFWINMDAAPARVGLGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRQHKELLRFRRKRRHHKSPMLNLFQDDEGGEGRFNFSAYGMGPACLQAKDGISVKGANNNNTTNPAPAPSKSPEEMRKLFIQRAKKIDKISRIGFPMAFLIFNMFYWIIYKIVRREDVHNK 8DN5,8DN4,8DN3,8DN2 Glycine receptor subunit alpha-1 GLRA1_RAT P07727 Q546L6 184751 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Histamine H1 receptor Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2295&target=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Histamine+H1+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS 9LRD,9LRB,8YN2,7DFL Histamine H1 receptor HRH1_HUMAN P35367 A8K047 Q6P9E5 184752 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Histamine H2 receptor Cavia porcellus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2298&target=Histamine+H2+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Histamine+H2+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR Histamine H2 receptor HRH2_CAVPO P47747 184753 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000682&target=Phosphatidylinositol+3%2C4%2C5-trisphosphate+5-phosphatase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Phosphatidylinositol+3%2C4%2C5-trisphosphate+5-phosphatase+2&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MASVCGAPSPGGALGSQAPAWYHRDLSRAAAEELLARAGRDGSFLVRDSESVAGAFALCVLYQKHVHTYRILPDGEDFLAVQTSQGVPVRRFQTLGELIGLYAQPNQGLVCALLLPVEGEREPDPPDDRDASDVEDEKPPLPPRSGSTSISVPAGPSSPLPAPETPTTPAAESTPNGLSTVSHEYLKGSYGLDLEAVRGGASNLPHLTRTLVTSCRRLHSEVDKVLSGLEILSKVFDQQSSPMVTRLLQQQSLPQTGEQELESLVLKLSVLKDFLSGIQKKALKALQDMSSTAPPAPLQPSIRKAKTIPVQAFEVKLDVTLGDLTKIGKSQKFTLSVDVEGGRLVLLRRQRDSQEDWTTFTHDRIRQLIKSQRVQNKLGVVFEKEKDRTQRKDFIFVSARKREAFCQLLQLMKNKHSKQDEPDMISVFIGTWNMGSVPPPKNVTSWFTSKGLGKALDEVTVTIPHDIYVFGTQENSVGDREWLDLLRGGLKELTDLDYRPIAMQSLWNIKVAVLVKPEHENRISHVSTSSVKTGIANTLGNKGAVGVSFMFNGTSFGFVNCHLTSGNEKTTRRNQNYLDILRLLSLGDRQLSAFDISLRFTHLFWFGDLNYRLDMDIQEILNYISRREFEPLLRVDQLNLEREKHKVFLRFSEEEISFPPTYRYERGSRDTYAWHKQKPTGVRTNVPSWCDRILWKSYPETHIICNSYGCTDDIVTSDHSPVFGTFEVGVTSQFISKKGLSKTSDQAYIEFESIEAIVKTASRTKFFIEFYSTCLEEYKKSFENDAQSSDNINFLKVQWSSRQLPTLKPILADIEYLQDQHLLLTVKSMDGYESYGECVVALKSMIGSTAQQFLTFLSHRGEETGNIRGSMKVRVPTERLGTRERLYEWISIDKDDTGAKSKAPSVLRGSQEHRSGSRKPTSTEASCPLSKLFEEPEKPPPTGRPPAPPRAVPREESLNPRLKSEGTPEQEGVAAPPPKNSFNNPAYYVLEGVPHQLLPLEPTSFARAPIPPTTKNKVAITVPAPQLGRHRTPRVGEGSSSDEDSGGTLPPPDFPPPPLPDSAIFLPPNLDPLSMPVVRGRSVGEARGPPPPKAHPRPPLPPGTSPASTFLEEVASADDRSCSVLQMAKTLSEVDYSPGPGRSALLPNPLELQLPRGPSDYGRPLSFPPPRIRESIQEDLAEEAPCPQGGRASGLGEAGMGAWLRAIGLERYEEGLVHNGWDDLEFLSDITEEDLEEAGVQDPAHKRLLLDTLQLSK 5OKN Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 SHIP2_RAT Q9WVR3 Q9R1V2 184754 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Melatonin receptor type 1A Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5661&target=Melatonin+receptor+type+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Melatonin+receptor+type+1A&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MQGNGSALPNASQPVLRGDGARPSWLASALACVLIFTIVVDILGNLLVILSVYRNKKLRNAGNIFVVSLAVADLVVAIYPYPLVLMSIFNNGWNLGYLHCQVSGFLMGLSVIGSIFNITGIAINRYCYICHSLKYDKLYSSKNSLCYVLLIWLLTLAAVLPNLRAGTLQYDPRIYSCTFAQSVSSAYTIAVVVFHFLVPMIIVIFCYLRIWILVLQVRQRVKPDRKPKLKPQDFRNFVTMFVVFVLFAICWAPLNFIGLAVASDPASMVPRIPEWLFVASYYMAYFNSCLNAIIYGLLNQNFRKEYRRIIVSLCTARVFFVDSSNDVADRVKWKPSPLMTNNNVVKVDSV 7VGZ,7VGY Melatonin receptor type 1A MTR1A_HUMAN P48039 A0AVC5 B0M0L2 184755 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Acetylcholine receptor subunit alpha Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9680&target=Acetylcholine+receptor+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Acetylcholine+receptor+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MEPWPLLLLFSLCSAGLVLGSEHETRLVAKLFKDYSSVVRPVEDHRQVVEVTVGLQLIQLINVDEVNQIVTTNVRLKQGDMVDLPRPSCVTLGVPLFSHLQNEQWVDYNLKWNPDDYGGVKKIHIPSEKIWRPDLVLYNNADGDFAIVKFTKVLLQYTGHITWTPPAIFKSYCEIIVTHFPFDEQNCSMKLGTWTYDGSVVAINPESDQPDLSNFMESGEWVIKESRGWKHSVTYSCCPDTPYLDITYHFVMQRLPLYFIVNVIIPCLLFSFLTGLVFYLPTDSGEKMTLSISVLLSLTVFLLVIVELIPSTSSAVPLIGKYMLFTMVFVIASIIITVIVINTHHRSPSTHVMPNWVRKVFIDTIPNIMFFSTMKRPSREKQDKKIFTEDIDISDISGKPGPPPMGFHSPLIKHPEVKSAIEGIKYIAETMKSDQESNNAAAEWKYVAMVMDHILLGVFMLVCIIGTLAVFAGRLIELNQQG 9DMV,9DMT,9DMS,9DMQ,9DML,9DMK,9DMJ,9DMH,9DMG,9GU3,9GU2,9GU1,9GU0 Acetylcholine receptor subunit alpha ACHA_HUMAN P02708 B4DRV6 D3DPE8 184756 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Substance-P receptor Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2104&target=Substance-P+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Substance-P+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MDNVLPMDSDLFPNISTNTSESNQFVQPTWQIVLWAAAYTVIVVTSVVGNVVVIWIILAHKRMRTVTNYFLVNLAFAEACMAAFNTVVNFTYAVHNVWYYGLFYCKFHNFFPIAALFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVIFVIWVLALLLAFPQGYYSTTETMPSRVVCMIEWPEHPNRTYEKAYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHVFFLLPYINPDLYLKKFIQQVYLASMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAGDYEGLEMKSTRYLQTQSSVYKVSRLETTISTVVGAHEEEPEEGPKATPSSLDLTSNGSSRSNSKTMTESSSFYSNMLA Substance-P receptor NK1R_RAT P14600 184757 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Substance-K receptor Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000788&target=Substance-K+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Substance-K+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MGTRAIVSDANILSGLESNATGVTAFSMPGWQLALWATAYLALVLVAVTGNATVIWIILAHERMRTVTNYFIINLALADLCMAAFNATFNFIYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQPRLSAPSTKAIIAGIWLVALALASPQCFYSTITVDEGATKCVVAWPNDNGGKMLLLYHLVVFVLIYFLPLLVMFGAYSVIGLTLWKRAVPRHQAHGANLRHLQAKKKFVKAMVLVVLTFAICWLPYHLYFILGTFQEDIYYHKFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTEEDRLELTHTPSLSRRVNRCHTKETLFMTGDMTHSEATNGQVGSPQDGEPAGPICKAQA Substance-K receptor NK2R_RAT P16610 184758 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Neuromedin-K receptor Mus musculus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000795&target=Neuromedin-K+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Neuromedin-K+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MASVPTGENWTDGTAGVGSHTGNLSAALGITEWLALQAGNFSSALGLPVTSQAPSQVRANLTNQFVQPSWRIALWSLAYGLVVAVAVFGNLIVIWIILAHKRMRTVTNYFLVNLAFSDASVAAFNTLVNFIYGVHSEWYFGANYCRFQNFFPITAVFASIYSMTAIAVDRYMAIIDPLKPRLSATATKIVIGSIWILAFLLAFPQCLYSKIKVMPGRTLCYVQWPEGPKQHFTYHIIVIILVYCFPLLIMGVTYTIVGITLWGGEIPGDTCDKYHEQLKAKRKVVKMMIIVVVTFAICWLPYHVYFILTAIYQQLNRWKYIQQVYLASFWLAMSSTMYNPIIYCCLNKRFRAGFKRAFRWCPFIQVSSYDELELKTTRFHPTRQSSLYTVSRMESVTVLYDPSEGDPAKSSRKKRAVPRDPSANGCSHREFKSASTTSSFISSPYTSVDEYS Neuromedin-K receptor NK3R_MOUSE P47937 Q61968 Q8BL44 Q9JKN0 184759 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Nitric oxide synthase, brain Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2223&target=Nitric+oxide+synthase%2C+brain&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Nitric+oxide+synthase%2C+brain&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MEENTFGVQQIQPNVISVRLFKRKVGGLGFLVKERVSKPPVIISDLIRGGAAEQSGLIQAGDIILAVNDRPLVDLSYDSALEVLRGIASETHVVLILRGPEGFTTHLETTFTGDGTPKTIRVTQPLGPPTKAVDLSHQPSASKDQSLAVDRVTGLGNGPQHAQGHGQGAGSVSQANGVAIDPTMKSTKANLQDIGEHDELLKEIEPVLSILNSGSKATNRGGPAKAEMKDTGIQVDRDLDGKSHKAPPLGGDNDRVFNDLWGKDNVPVILNNPYSEKEQSPTSGKQSPTKNGSPSRCPRFLKVKNWETDVVLTDTLHLKSTLETGCTEHICMGSIMLPSQHTRKPEDVRTKDQLFPLAKEFLDQYYSSIKRFGSKAHMDRLEEVNKEIESTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKAPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFDWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMDLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWKGTNGTPTKRRAIGFKKLAEAVKFSAKLMGQAMAKRVKATILYATETGKSQAYAKTLCEIFKHAFDAKAMSMEEYDIVHLEHEALVLVVTSTFGNGDPPENGEKFGCALMEMRHPNSVQEERKSYKVRFNSVSSYSDSRKSSGDGPDLRDNFESTGPLANVRFSVFGLGSRAYPHFCAFGHAVDTLLEELGGERILKMREGDELCGQEEAFRTWAKKVFKAACDVFCVGDDVNIEKPNNSLISNDRSWKRNKFRLTYVAEAPDLTQGLSNVHKKRVSAARLLSRQNLQSPKFSRSTIFVRLHTNGNQELQYQPGDHLGVFPGNHEDLVNALIERLEDAPPANHVVKVEMLEERNTALGVISNWKDESRLPPCTIFQAFKYYLDITTPPTPLQLQQFASLATNEKEKQRLLVLSKGLQEYEEWKWGKNPTMVEVLEEFPSIQMPATLLLTQLSLLQPRYYSISSSPDMYPDEVHLTVAIVSYHTRDGEGPVHHGVCSSWLNRIQADDVVPCFVRGAPSFHLPRNPQVPCILVGPGTGIAPFRSFWQQRQFDIQHKGMNPCPMVLVFGCRQSKIDHIYREETLQAKNKGVFRELYTAYSREPDRPKKYVQDVLQEQLAESVYRALKEQGGHIYVCGDVTMAADVLKAIQRIMTQQGKLSEEDAGVFISRLRDDNRYHEDIFGVTLRTYEVTNRLRSESIAFIEESKKDADEVFSS 8T1K,8T1J,1F20,8FGC,8FGB,8FGA,8FG9,7TSF,7S40,7S3Z,7S3Y,7S3X,6PN9,6PN8,6PN7,6PN6,6PN5,6PN4,6PN3,6PN2,6PN1,6PN0,6PMZ,6PMY,6PMX,6PMW,6PMV,6NHE,6NHD,6NH0,6NGZ,6NGY,6NGX,6NGW,6NGV,6NGU,6NGT,6NGS,6NGR,6NGQ,6NGP,6NGN,6NGM,6NGL,6NGK,6NGJ,6AUX,6AUW,6AUV,6AUU,6AUT,6AUS,6AUR,6AUQ,5VUU,5VUT,5VUS,5VUR,5VUQ,5VUP,5VUO,5VUN,5VUM,5VUL,5VUK,5VUJ,5VUI,5UO0,5UNZ,5UNY,5UNX,5UNW,5UNV,5UNU,5UNT,5UNS,5UNR,5FW0,5FVT,5FVS,5FVR,5FVQ,5FVP,5FVO,5AGP,5AGO,5AGN,5AGM,5AGL,5AGK,5ADC,5ADB,5ADA,5AD9,5AD8,5AD7,5AD6,5AD5,5AD4,4V3Z,4V3Y,4V3X,4V3W,4V3V,4UPP,4UPO,4UPN,4UPM,4UH4,4UH3,4UH2,4UH1,4UH0,4UGZ,4LUX,4KCO,4KCN,4KCM,4KCL,4KCK,4KCJ,4KCI,4KCH,4K5G,4K5F,4K5D,4JSJ,4JSI,4JSH,4JSF,4JSE,4IMW,4IMU,4IMT,4IMS,4GQE,4FW0,4FVZ,4FVY,4FVX,4FVW,4EUX,4D7O,4D3B,4D32,4D31,4D30,4D2Z,4D2Y,4CTX,4CTW,4CTV,4CTU,4CTT,4CTR,4CTQ,4CTP,4CDT,4CAQ,4CAP,4CAO,4CAN,4CAM,4C39,3UFW,3UFV,3UFU,3UFT,3UFS,3UFR,3UFQ,3UFP,3UFO,3TYO,3TYN,3TYM,3TYL,3SVQ,3SVP,3RQN,3RQM,3RQL,3RQK,3RQJ,3Q9A,3Q99,3PNG,3PNF,3PNE,3NNZ,3NNY,3NM0,3NLZ,3NLY,3NLX,3NLW,3NLV,3NLM,3N60,3N5Z,3N5Y,3N5X,3N5W,3N5V,3N2R,3JTA,3JT9,3JT8,3JT7,3JT6,3JT5,3JT4,3JT3,3HSP,3HSO,3HSN,3B3P,3B3O,3B3N,3B3M,2HX4,2HX3,1OM4,1RS7,1RS6,1P6J,1P6I Nitric oxide synthase 1 NOS1_RAT P29476 P70594 184760 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Sodium-dependent noradrenaline transporter Homo sapiens 5 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI 8Z1L,8YR2,8Y95,8Y94,8Y93,8Y92,8Y91,8Y90,8Y8Z,8WGX,8WGR,8I3V,8HFL,8HFI,8HFG,8HFF,8HFE,8ZPB,8ZP2,8ZP1,8ZOY,8WTY,8WTX,8WTW,8WTV,8WTU Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 184761 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3 SNPPWIUOZRMYNY-UHFFFAOYSA-N 50048392 BUPROPION HYDROCHLORIDE::CHEMBL894::2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one::BUPROPION::US9944618, Compound ID No. 176 Sodium-dependent noradrenaline transporter Homo sapiens >10000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50048392 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50048392&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 444 103978858 CHEMBL894 DB01156 C06860 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI 8Z1L,8YR2,8Y95,8Y94,8Y93,8Y92,8Y91,8Y90,8Y8Z,8WGX,8WGR,8I3V,8HFL,8HFI,8HFG,8HFF,8HFE,8ZPB,8ZP2,8ZP1,8ZOY,8WTY,8WTX,8WTW,8WTV,8WTU Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 184762 CNCCCN1c2ccccc2CCc3c1cccc3 InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3 HCYAFALTSJYZDH-UHFFFAOYSA-N 35229 Desmethylimipramine::3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1-amine::monodemethylimipramine::Desipramin::5-(gamma-methylaminopropyl)iminodibenzyl::norimipramine::CHEMBL72::DESIPRAMINE HYDROCHLORIDE::demethylimipramine::N-(3-methylaminopropyl)iminobibenzyl::DMI::Desipramine::US9944618, Compound ID No. 174 Sodium-dependent noradrenaline transporter Homo sapiens 3.8 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=35229&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search DSM 7Q19,2QJU,7Q2N,7Q2O,7Q2P,8HFI,8WGR,2QB4 2995 85753308 CHEMBL72 DB01151 C06943 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI 8Z1L,8YR2,8Y95,8Y94,8Y93,8Y92,8Y91,8Y90,8Y8Z,8WGX,8WGR,8I3V,8HFL,8HFI,8HFG,8HFF,8HFE,8ZPB,8ZP2,8ZP1,8ZOY,8WTY,8WTX,8WTW,8WTV,8WTU Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 184763 CNCC[C@H](c1ccccc1)Oc2ccc(cc2)C(F)(F)F InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 30130 Prozac::cid_62857::Fluoxetin::CHEMBL41::CHEMBL1201082::Fluoxetine::US9120771, Fluoxetine Sodium-dependent noradrenaline transporter Homo sapiens 1022 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=30130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=30130&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search RFX 4MM8,3GWV 3386 85147891 CHEMBL1201082CHEMBL41 DB00472 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI 8Z1L,8YR2,8Y95,8Y94,8Y93,8Y92,8Y91,8Y90,8Y8Z,8WGX,8WGR,8I3V,8HFL,8HFI,8HFG,8HFF,8HFE,8ZPB,8ZP2,8ZP1,8ZOY,8WTY,8WTX,8WTW,8WTV,8WTU Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 184764 CN(C)CCCN1c2ccccc2CCc3c1cccc3 InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3 BCGWQEUPMDMJNV-UHFFFAOYSA-N 50010859 CHEMBL11::Imipramin::IMIPRAMINE HYDROCHLORIDE::IMIPRAMINE PAMOATE Sodium-dependent noradrenaline transporter Homo sapiens 98 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50010859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50010859&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search IXX 2Q72,7LWD,6G9B 3696 103923605 CHEMBL11 DB00458 C07049 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI 8Z1L,8YR2,8Y95,8Y94,8Y93,8Y92,8Y91,8Y90,8Y8Z,8WGX,8WGR,8I3V,8HFL,8HFI,8HFG,8HFF,8HFE,8ZPB,8ZP2,8ZP1,8ZOY,8WTY,8WTX,8WTW,8WTV,8WTU Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 184765 COC(=O)[C@H]([C@@H]1CCCCN1)c1ccccc1 InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3 DUGOZIWVEXMGBE-UHFFFAOYSA-N 50050098 CHEMBL542556::METHYLPHENIDATE::(S)-Phenyl-(S)-piperidin-2-yl-acetic acid methyl ester; hydrochloride Sodium-dependent noradrenaline transporter Homo sapiens 339 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50050098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50050098&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 10657292 103947285 CHEMBL542556 C07196 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI 8Z1L,8YR2,8Y95,8Y94,8Y93,8Y92,8Y91,8Y90,8Y8Z,8WGX,8WGR,8I3V,8HFL,8HFI,8HFG,8HFF,8HFE,8ZPB,8ZP2,8ZP1,8ZOY,8WTY,8WTX,8WTW,8WTV,8WTU Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 184766 CN1Cc2c(cccc2N)[C@@H](C1)c3ccccc3 InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3 XXPANQJNYNUNES-UHFFFAOYSA-N 50005548 (+/-)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine (Nomifensine)::2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::CHEMBL273575::(+)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::(Nomifensine) 2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-8-amine::NOMIFENSINE2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::(-)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine::2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine(Nomifensine)::NOMIFENSINE Sodium-dependent noradrenaline transporter Homo sapiens 29 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50005548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50005548&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search A1LX5 8Y91 4528 103919027 CHEMBL273575 DB04821 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI 8Z1L,8YR2,8Y95,8Y94,8Y93,8Y92,8Y91,8Y90,8Y8Z,8WGX,8WGR,8I3V,8HFL,8HFI,8HFG,8HFF,8HFE,8ZPB,8ZP2,8ZP1,8ZOY,8WTY,8WTX,8WTW,8WTV,8WTU Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 184767 CCOc1ccccc1O[C@@H](c2ccccc2)[C@@H]3CNCCO3 InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3 CBQGYUDMJHNJBX-UHFFFAOYSA-N 35226 Vestra::Reboxetine::(S,S)-reboxetine Sodium-dependent noradrenaline transporter Homo sapiens 11 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=35226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=35226&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search A1D9Y 8ZP1 65856 85753305 DB00234 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI 8Z1L,8YR2,8Y95,8Y94,8Y93,8Y92,8Y91,8Y90,8Y8Z,8WGX,8WGR,8I3V,8HFL,8HFI,8HFG,8HFF,8HFE,8ZPB,8ZP2,8ZP1,8ZOY,8WTY,8WTX,8WTW,8WTV,8WTU Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 184768 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Sodium-dependent noradrenaline transporter Homo sapiens 5 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI 8Z1L,8YR2,8Y95,8Y94,8Y93,8Y92,8Y91,8Y90,8Y8Z,8WGX,8WGR,8I3V,8HFL,8HFI,8HFG,8HFF,8HFE,8ZPB,8ZP2,8ZP1,8ZOY,8WTY,8WTX,8WTW,8WTV,8WTU Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 184769 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Neuropeptide Y receptor type 1 Homo sapiens 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000835&target=Neuropeptide+Y+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Neuropeptide+Y+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MNSTLFSQVENHSVHSNFSEKNAQLLAFENDDCHLPLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTNILIVNLSFSDLLVAIMCLPFTFVYTLMDHWVFGEAMCKLNPFVQCVSITVSIFSLVLIAVERHQLIINPRGWRPNNRHAYVGIAVIWVLAVASSLPFLIYQVMTDEPFQNVTLDAYKDKYVCFDQFPSDSHRLSYTTLLLVLQYFGPLCFIFICYFKIYIRLKRRNNMMDKMRDNKYRSSETKRINIMLLSIVVAFAVCWLPLTIFNTVFDWNHQIIATCNHNLLFLLCHLTAMISTCVNPIFYGFLNKNFQRDLQFFFNFCDFRSRDDDYETIAMSTMHTDVSKTSLKQASPVAFKKINNNDDNEKI 7VGX,8K6M,8K6O,5ZBH Neuropeptide Y receptor type 1 NPY1R_HUMAN P25929 B2R6H5 184770 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE 5'-nucleotidase Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9346&target=5%27-nucleotidase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=5%27-nucleotidase&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MRPAAATAPKWLLLALSALLPLWPTAKSWELTIMHTNDVHSRLEQTSDDSTKCLNASLCVGGVARLFTKVQQIRKEEPNVLLLDAGDQYQGTIWFTVYKGLEVAHFMNLLGYDAMALGNHEFDNGVEGLIDPLLRNVKFPILSANIKARGPLAPQISGLYLPYKVLSVGGEVVGIVGYTSKETPFLSNPGTNLVFEDEVTALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHTNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKVEFDDKGNVVTSYGNPILLNSTIREDAAIKADINQWRIKLDNYSTQELGRTIVYLNGSAQECRFRECNMGNLICDAMINNNLRHPDEMFWNHVSMCIVNGGGIRSPIDERNNGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDISRKPWDRVVQLKVLCTKCRVPIYEPLEMDKVYKVVLPSYLVNGGDGFQMIKDELLKHDSGDQDISVVSEYISKMKVIYPAVEGRIKFSAASHYQGSFPLIILSFWAVILVLYQ 9HJ4,7QGL,7QGA 5'-nucleotidase 5NTD_RAT P21588 184771 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Delta-type opioid receptor Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3138&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MEPVPSARAELQFSLLANVSDTFPSAFPSASANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCTLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRAPCGGQEPGSLRRPRQATARERVTACTPSDGPGGGAAA 8Y45 Delta-type opioid receptor OPRD_RAT P33533 184772 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Kappa-type opioid receptor Cavia porcellus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2124&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MGRRRQGPAQPASELPARNACLLPNGSAWLPGWAEPDGNGSAGPQDEQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIILGGTKVREDVDIIECSLQFPDDDYSWWDLFMKICVFVFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFIICWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPIKMRMERQSTSRVRNTVQDPAYMRNVDGVNKPV Kappa-type opioid receptor OPRK_CAVPO P41144 184773 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Mu-type opioid receptor Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2101&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MDSSTGPGNTSDCSDPLAQASCSPAPGSWLNLSHVDGNQSDPCGLNRTGLGGNDSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRVRQNTREHPSTANTVDRTNHQLENLEAETAPLP 4DKL Mu-type opioid receptor OPRM_RAT P33535 Q2TV20 Q2TV21 Q4VWM5 Q4VWM7 Q4VWX7 Q4VWX8 Q62846 Q64064 Q64120 184774 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Potassium voltage-gated channel subfamily H member 8 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000927&target=Potassium+voltage-gated+channel+subfamily+H+member+8&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+8&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MPVMKGLLAPQNTFLDTIATRFDGTHSNFILANAQVAKGFPIVYCSDGFCELAGFARTEVMQKSCSCKFLFGVETNEQLMLQIEKSLEEKVEFKGEIMFYKKNGAPFWCLLDIVPIKNEKGDVVLFLASFKDITDTKVKITSEDKKEDRAKGRSRAGSHFDSARRRSRAVLYHISGHLQRREKNKLKINNNVFVDKPAFPEYKVSDAKKSKFILLHFSTFKAGWDWLILLATFYVAVTVPYNVCFIGNEDLSTTRSTTVSDIAVEILFIIDIILNFRTTYVSKSGQVIFEARSICIHYVTTWFIIDLIAALPFDLLYAFNVTVVSLVHLLKTVRLLRLLRLLQKLDRYSQHSTIVLTLLMSMFALLAHWMACIWYVIGKMEREDNSLLKWEVGWLHELGKRLESPYYGNNTLGGPSIRSAYIAALYFTLSSLTSVGFGNVSANTDAEKIFSICTMLIGALMHALVFGNVTAIIQRMYSRWSLYHTRTKDLKDFIRVHHLPQQLKQRMLEYFQTTWSVNNGIDSNELLKDFPDELRSDITMHLNKEILQLSLFECASRGCLRSLSLHIKTSFCAPGEYLLRQGDALQAIYFVCSGSMEVLKDSMVLAILGKGDLIGANLSIKDQVIKTNADVKALTYCDLQCIILKGLFEVLGLYPEYAHKFVEDIQHDLTYNLREGHESDVISRLSNKSTVPQAEPKGNGSIKKRLPSIVEDEEEEEVEEEETTSLSPIYTRGSSVSHSKKTGSSKSYLGLSLKQLTSGTVPFHSPIRVSSANSPKTKQEADPPNHGTRKEKNLKVQLCSLGTAGTPELSPRIVDGIEDGNSSEETQTFDFGSEQIRPEPRISPSLGESEIGAAFLFIKAEETKQQINKLNSEVTTLTQEVSQLGKDMRSIMQLLENILSPQQPSQFCSLHPTSICPSRESFQTRVSWSAHQPCLHLQANGAHLYHGNVTSDIWSVDPSLVGSNPQRTEAHEQSPVDSELHHSPNLAYSPSHCQVIQEGHLQFLRCISPHSDTTLTPLQSISATLSSSVCSSSETSLHLVLPSRSEEGSITHGPVSSFSLENLPGSWDREGMMSASTEPLENFPVEVVTSTADVKDSKAINV Voltage-gated delayed rectifier potassium channel KCNH8 KCNH8_RAT Q9QWS8 O88877 184775 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE ATP-sensitive inward rectifier potassium channel 1 Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7148&target=ATP-sensitive+inward+rectifier+potassium+channel+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=ATP-sensitive+inward+rectifier+potassium+channel+1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MGASERSVFRVLIRALTERMFKHLRRWFITHIFGRSRQRARLVSKEGRCNIEFGNVDAQSRFIFFVDIWTTVLDLKWRYKMTVFITAFLGSWFLFGLLWYVVAYVHKDLPEFYPPDNRTPCVENINGMTSAFLFSLETQVTIGYGFRFVTEQCATAIFLLIFQSILGVIINSFMCGAILAKISRPKKRAKTITFSKNAVISKRGGKLCLLIRVANLRKSLLIGSHIYGKLLKTTITPEGETIILDQTNINFVVDAGNENLFFISPLTIYHIIDHNSPFFHMAAETLSQQDFELVVFLDGTVESTSATCQVRTSYVPEEVLWGYRFVPIVSKTKEGKYRVDFHNFGKTVEVETPHCAMCLYNEKDARARMKRGYDNPNFVLSEVDETDDTQM ATP-sensitive inward rectifier potassium channel 1 KCNJ1_RAT P35560 O88639 O88640 Q9QUR5 184776 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Protein kinase C alpha type Mus musculus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000969&target=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MADVYPANDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINDPSLCGMDHTEKRGRIYLKAEVTDEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSNLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKAHNQEEGEYYNVPIPEGDEEGNMELRQKFEKAKLGPVGNKVISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLNNVMLNSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKQPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV Protein kinase C alpha type KPCA_MOUSE P20444 184777 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Sigma non-opioid intracellular receptor 1 Cavia porcellus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4936&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MQWAVGRRWLWVALFLAAVAVLTQIVWLWLGTQNFVFQREEIAQLARQYAGLDHELAFSKLIVELRRLHPVHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSPRHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLGFALADTVFSTQDFLTLFYTLRVYARALQLELTTYLFGQDP Sigma non-opioid intracellular receptor 1 SGMR1_CAVPO Q60492 184778 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Sigma non-opioid intracellular receptor 1 Cavia porcellus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4936&target=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Sigma+non-opioid+intracellular+receptor+1&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MQWAVGRRWLWVALFLAAVAVLTQIVWLWLGTQNFVFQREEIAQLARQYAGLDHELAFSKLIVELRRLHPVHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSPRHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLGFALADTVFSTQDFLTLFYTLRVYARALQLELTTYLFGQDP Sigma non-opioid intracellular receptor 1 SGMR1_CAVPO Q60492 184779 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Sodium channel protein type 1 subunit alpha Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000743&target=Sodium+channel+protein+type+1+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Sodium+channel+protein+type+1+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MEQTVLVPPGPDSFNFFTRESLAAIERRIAEEKAKNPKPDKKDDDENGPKPNSDLEAGKNLPFIYGDIPPEMVSEPLEDLDPYYINKKTFIVLNKGKAIFRFSATSALYILTPFNPLRKIAIKILVHSLFSMLIMCTILTNCVFMTMSNPPDWTKNVEYTFTGIYTFESLIKIIARGFCLEDFTFLRDPWNWLDFTVITFAYVTEFVDLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVMILTVFCLSVFALIGLQLFMGNLRNKCVQWPPTNASLEEHSIEKNVTTDYNGTLVNETVFEFDWKSYIQDSRYHYFLEGVLDALLCGNSSDAGQCPEGYMCVKAGRNPNYGYTSFDTFSWAFLSLFRLMTQDFWENLYQLTLRAAGKTYMIFFVLVIFLGSFYLINLILAVVAMAYEEQNQATLEEAEQKEAEFQQMLEQLKKQQEAAQQAAAATASEHSREPSAAGRLSDSSSEASKLSSKSAKERRNRRKKRKQKEQSGGEEKDDDEFHKSESEDSIRRKGFRFSIEGNRLTYEKRYSSPHQSLLSIRGSLFSPRRNSRTSLFSFRGRAKDVGSENDFADDEHSTFEDNESRRDSLFVPRRHGERRNSNLSQTSRSSRMLAGLPANGKMHSTVDCNGVVSLVGGPSVPTSPVGQLLPEVIIDKPATDDNGTTTETEMRKRRSSSFHVSMDFLEDPSQRQRAMSIASILTNTVEELEESRQKCPPCWYKFSNIFLIWDCSPYWLKVKHIVNLVVMDPFVDLAITICIVLNTLFMAMEHYPMTEHFNHVLTVGNLVFTGIFTAEMFLKIIAMDPYYYFQEGWNIFDGFIVTLSLVELGLANVEGLSVLRSFRLLRVFKLAKSWPTLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKDCVCKIATDCKLPRWHMNDFFHSFLIVFRVLCGEWIETMWDCMEVAGQAMCLTVFMMVMVIRNLVVLNLFLALLLSSFSADNLAATDDDNEMNNLQIAVDRMHKGVAYVKRKIYEFIQQSFVRKQKILDEIKPLDDLNNRKDNCTSNHTTEIGKDLDCLKDVNGTTSGIGTGSSVEKYIIDESDYMSFINNPSLTVTVPIAVGESDFENLNTEDFSSESDLEESKEKLNESSSSSEGSTVDIGAPAEEQPVMEPEETLEPEACFTEGCVQRFKCCQISVEEGRGKQWWNLRRTCFRIVEHNWFETFIVFMILLSSGALAFEDIYIDQRKTIKTMLEYADKVFTYIFILEMLLKWVAYGYQTYFTNAWCWLDFLIVDVSLVSLTANALGYSELGAIKSLRTLRALRPLRALSRFEGMRVVVNALLGAIPSIMNVLLVCLIFWLIFSIMGVNLFAGKFYHCVNTTTGDTFEITEVNNHSDCLKLIERNETARWKNVKVNFDNVGFGYLSLLQVATFKGWMDIMYAAVDSRNVELQPKYEESLYMYLYFVIFIIFGSFFTLNLFIGVIIDNFNQQKKKFGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPGNKFQGMVFDFVTRQVFDISIMILICLNMVTMMVETDDQSDYVTSILSRINLVFIVLFTGECVLKLISLRHYYFTIGWNIFDFVVVILSIVGMFLAELIEKYFVSPTLFRVIRLARIGRILRLIKGAKGIRTLLFALMMSLPALFNIGLLLFLVMFIYAIFGMSNFAYVKREVGIDDMFNFETFGNSMICLFQITTSAGWDGLLAPILNSKPPDCDPNKVNPGSSVKGDCGNPSVGIFFFVSYIIISFLVVVNMYIAVILENFSVATEESAEPLSEDDFEMFYEVWEKFDPDATQFMEFEKLSQFAAALEPPLNLPQPNKLQLIAMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDALRIQMEERFMASNPSKVSYQPITTTLKRKQEEVSAVIIQRAYRRHLLKRTVKQASFTYNKNKLKGGANLLVKEDMIIDRINENSITEKTDLTMSTAACPPSYDRVTKPIVEKHEQEGKDEKAKGK 7DTD,6J8E Sodium channel protein type 1 subunit alpha SCN1A_RAT P04774 184780 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Sodium channel protein type 2 subunit alpha Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000744&target=Sodium+channel+protein+type+2+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Sodium+channel+protein+type+2+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MARSVLVPPGPDSFRFFTRESLAAIEQRIAEEKAKRPKQERKDEDDENGPKPNSDLEAGKSLPFIYGDIPPEMVSEPLEDLDPYYINKKTFIVLNKGKAISRFSATSALYILTPFNPIRKLAIKILVHSLFNVLIMCTILTNCVFMTMSNPPDWTKNVEYTFTGIYTFESLIKILARGFCLEDFTFLRNPWNWLDFTVITFAYVTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVMILTVFCLSVFALIGLQLFMGNLRNKCLQWPPDNSTFEINITSFFNNSLDWNGTAFNRTVNMFNWDEYIEDKSHFYFLEGQNDALLCGNSSDAGQCPEGYICVKAGRNPNYGYTSFDTFSWAFLSLFRLMTQDFWENLYQLTLRAAGKTYMIFFVLVIFLGSFYLINLILAVVAMAYEEQNQATLEEAEQKEAEFQQMLEQLKKQQEEAQAAAAAASAESRDFSGAGGIGVFSESSSVASKLSSKSEKELKNRRKKKKQKEQAGEEEKEDAVRKSASEDSIRKKGFQFSLEGSRLTYEKRFSSPHQSLLSIRGSLFSPRRNSRASLFNFKGRVKDIGSENDFADDEHSTFEDNDSRRDSLFVPHRHGERRPSNVSQASRASRGIPTLPMNGKMHSAVDCNGVVSLVGGPSALTSPVGQLLPEGTTTETEIRKRRSSSYHVSMDLLEDPSRQRAMSMASILTNTMEELEESRQKCPPCWYKFANMCLIWDCCKPWLKVKHVVNLVVMDPFVDLAITICIVLNTLFMAMEHYPMTEQFSSVLSVGNLVFTGIFTAEMFLKIIAMDPYYYFQEGWNIFDGFIVSLSLMELGLANVEGLSVLRSFRLLRVFKLAKSWPTLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKISNDCELPRWHMHHFFHSFLIVFRVLCGEWIETMWDCMEVAGQTMCLTVFMMVMVIGNLVVLNLFLALLLSSFSSDNLAATDDDNEMNNLQIAVGRMQKGIDFVKRKIREFIQKAFVRKQKALDEIKPLEDLNNKKDSCISNHTTIEIGKDLNYLKDGNGTTSGIGSSVEKYVVDESDYMSFINNPSLTVTVPIALGESDFENLNTEEFSSESDMEESKEKLNATSSSEGSTVDIGAPAEGEQPEAEPEESLEPEACFTEDCVRKFKCCQISIEEGKGKLWWNLRKTCYKIVEHNWFETFIVFMILLSSGALAFEDIYIEQRKTIKTMLEYADKVFTYIFILEMLLKWVAYGFQMYFTNAWCWLDFLIVDVSLVSLTANALGYSELGAIKSLRTLRALRPLRALSRFEGMRVVVNALLGAIPSIMNVLLVCLIFWLIFSIMGVNLFAGKFYHCINYTTGEMFDVSVVNNYSECQALIESNQTARWKNVKVNFDNVGLGYLSLLQVATFKGWMDIMYAAVDSRNVELQPKYEDNLYMYLYFVIFIIFGSFFTLNLFIGVIIDNFNQQKKKFGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPANKFQGMVFDFVTKQVFDISIMILICLNMVTMMVETDDQSQEMTNILYWINLVFIVLFTGECVLKLISLRHYYFTIGWNIFDFVVVILSIVGMFLAELIEKYFVSPTLFRVIRLARIGRILRLIKGAKGIRTLLFALMMSLPALFNIGLLLFLVMFIYAIFGMSNFAYVKREVGIDDMFNFETFGNSMICLFQITTSAGWDGLLAPILNSGPPDCDPEKDHPGSSVKGDCGNPSVGIFFFVSYIIISFLVVVNMYIAVILENFSVATEESAEPLSEDDFEMFYEVWEKFDPDATQFIEFCKLSDFAAALDPPLLIAKPNKVQLIAMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDALRIQMEERFMASNPSKVSYEPITTTLKRKQEEVSAIVIQRAYRRYLLKQKVKKVSSIYKKDKGKEDEGTPIKEDIITDKLNENSTPEKTDVTPSTTSPPSYDSVTKPEKEKFEKDKSEKEDKGKDIRESKK 6J8E,1BYY,2M5E,2KXW Sodium channel protein type 2 subunit alpha SCN2A_RAT P04775 184781 CNCCC(Oc1ccccc1C)c1ccccc1 InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3 VHGCDTVCOLNTBX-UHFFFAOYSA-N 50022784 Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine(tomoxetine)::Methyl-(3-phenyl-3-o-tolyloxy-propyl)-amine::Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine::CHEMBL641::(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine::Tomoxetine::Strattera::ATOMOXETINE Somatostatin Rattus norvegicus 1000 PDSP Ki 10.1016/S0893-133X(02)00346-9 10.7270/Q2GQ6W98 12431845 Bymaster, FP; Katner, JS; Nelson, DL; Hemrick-Luecke, SK; Threlkeld, PG; Heiligenstein, JH; Morin, SM; Gehlert, DR; Perry, KW 12/28/2002 5/13/2012 Eli Lilly http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001015&target=Somatostatin&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50022784&enzyme=Somatostatin&column=ki&startPg=0&Increment=50&submit=Search 6850813 103933341 CHEMBL641 1 MLSCRLQCALAALCIVLALGGVTGAPSDPRLRQFLQKSLAAATGKQELAKYFLAELLSEPNQTENDALEPEDLPQAAEQDEMRLELQRSANSNPAMAPRERKAGCKNFFWKTFTSC 8ZBJ,8ZBI,7XMS,7XMR,7XAT,7WJ5,7WIC,7T10,2MI1,7Y27,7VV4,7VDL,7S8M,7S8L,6Y1Q Somatostatin SMS_RAT P60042 P01167